David Dermot Patrick Laffan

Title: David Dermot Patrick Laffan: Innovator in Pharmaceutical Chemistry

Introduction

David Dermot Patrick Laffan is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on the development of innovative processes for the manufacture of pharmaceutical compounds.

Latest Patents

Laffan's latest patents include a process for the manufacture of the calcium salt of rosuvastatin. This compound is recognized for its utility as an HMG-CoA reductase inhibitor. The patent describes a method involving isolated crystalline compounds, which are crucial for the effective production of this important medication. Another notable patent is for a phthalazinone derivative, specifically 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one, presented as crystalline Form A. These innovations highlight Laffan's expertise in creating valuable pharmaceutical intermediates.

Career Highlights

Throughout his career, Laffan has worked with prominent companies in the pharmaceutical industry. He has been associated with Kudos Pharmaceuticals Limited and AstraZeneca UK Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Laffan has collaborated with esteemed colleagues, including Keith Allan Menear and Anthony Peter Ottridge. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their shared field.

Conclusion

David Dermot Patrick Laffan is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important patents. His contributions continue to impact the industry positively, showcasing the importance of innovation in healthcare.